Drugs / S230815
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07227857 | Nov 2025 → Apr 2028 expected | genetic developmental and epileptic encephalopathy | Servier | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | S230815 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07227857 ↗ |
| Route | Intrathecal | “Intrathecal S230815” NCT07227857 ↗ |